Deepak Builders & Engineers makes a disappointing debut; lists with over 2% discount

Shares of Deepak Builders & Engineers had a subdued debut on the stock exchanges today, listing at a discount on both the NSE and BSE. The stock opened at Rs 200 on the NSE, reflecting a 1.48% drop from its IPO price of Rs 203.

Similarly, on the BSE, the stock listed at Rs 198.50, marking a 2.22% decline from its issue price, indicating a muted response from the market on its first trading day.

Deepak Builders & Engineers IPO Subscription Status

Despite a downturn in broader equity markets, investor confidence remained high for Deepak Builders & Engineers India, whose IPO saw bids for 37.24 crore equity shares—41.54 times the offer size of 89.67 lakh shares.

Demand was led by non-institutional investors (HNIs), who subscribed to 82.47 times their allotment, while retail investors followed closely, with 39.79 times subscription of their reserved portion. Qualified institutional buyers also demonstrated robust interest, subscribing 13.91 times their allocated shares.

Where Will Be The Money Raised By IPO Used?

The Ludhiana-based construction company, Deepak Builders & Engineers India, raised Rs 78 crore from anchor investors on October 18.

Also ReadWaaree Energies makes stellar debut on D-Street; Lists at 66% premium

The company has outlined plans to allocate Rs 142 crore from the fresh issue proceeds to repay debt and bolster working capital needs, with remaining funds directed towards general corporate purposes.

About Deepak Builders & Engineers

Founded in 2017, Deepak Builders & Engineers India Limited has built a reputation as a specialized construction service provider. The company undertakes a diverse range of projects, from administrative and institutional buildings to hospitals, stadiums, and residential complexes.

Their turnkey projects span a comprehensive suite of services, including architecture, civil work, MEP (mechanical, electrical, plumbing), firefighting, IT systems, medical gas pipelines, and landscaping, catering to both government and private sector clients.

 » Read More

Related Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

‘Pramerica Life targets Rs 3,000-crore GWP in FY26,’ Pankaj Gupta

Pramerica Life Insurance, a joint venture between subsidiaries of Piramal Capital and Housing Finance and US-based Prudential Financial Inc, aims to close FY26 with Rs 3,000 crore in gross written premium. In an interview with Narayanan V, managing director and CEO Pankaj Gupta discusses the products and distribution strategy. Excerpts: Life insurance premiums have been

Tata small cap fund: Targeting growth at reasonable valuations

Tata Small Cap Fund is a growth-oriented scheme in the Small Cap Fund category that has exhibited a noteworthy track record since its inception and has outpaced many of its prominent peers, thereby rewarding investors with superior risk-adjusted returns. Launched in November 2018, Tata Small Cap Fund aims to invest in stocks of companies that are in growth